Losartan Potatssium

Product NDC
58517-240
11-digit product format
585170240
Labeler code
58517
Product ID
58517-240_3457501e-f3b7-48df-a874-ab25db0a4797
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Losartan Potatssium
Dosage form
TABLET
Route
ORAL
Labeler
New Horizon Rx Group, LLC
Application
ANDA078243
Marketing category
ANDA
Marketing start
2013-08-25
Marketing end
0000-00-00
Substance
LOSARTAN POTASSIUM
Active strength
50 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0d341e63-aee5-498b-bf9a-b53a43963acfProduct name120260105
de29c5c0-90ba-29da-d7ab-0500274708beProduct name620241009
15b375b1-89c7-9594-80df-5a8c8864aee0Product name320180108

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
58517-240-302019-11-27C16284748780-19855e2a2-4c83-60a7-e053-dbdaa90a05bdLosartan Potassium Tablets, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58517-240-30Losartan Potatssium30 in 1 BOTTLETABLET304

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
58517-240-30EA - Each58517-24046a7e271-1fe5-4747-ad7b-7560cfe56d2512013-10-17

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LOSARTAN POTASSIUMACTIVE INGREDIENT3ST302B24ALOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
LOSARTANACTIVE MOIETYJMS50MPO89LOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDINACTIVE INGREDIENT2165RE0K14LOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOLOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XLOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2LOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJLOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
TALCINACTIVE INGREDIENT7SEV7J4R1ULOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58517-240LOSARTAN POTATSSIUM TABLET [NEW HORIZON RX GROUP, LLC]4Legacy NDC, 1 package rows20131231_4ef177d5-647b-4810-ad56-a3905f09e3f7.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
979492losartan potassium 50 MG Oral TabletPSN4ef177d5-647b-4810-ad56-a3905f09e3f74
979492losartan potassium 50 MG Oral TabletSCD4ef177d5-647b-4810-ad56-a3905f09e3f74
979492Losartan K+ 50 MG Oral TabletSY4ef177d5-647b-4810-ad56-a3905f09e3f74
979492Losartan Pot 50 MG Oral TabletSY4ef177d5-647b-4810-ad56-a3905f09e3f74

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
58517-240-305851702403030 in 1 BOTTLEHistorical